Reviva Pharmaceuticals Statistics Share Statistics Reviva Pharmaceuticals has 68M
shares outstanding. The number of shares has increased by 41.24%
in one year.
Shares Outstanding 68M Shares Change (YoY) 41.24% Shares Change (QoQ) 0.35% Owned by Institutions (%) 21.66% Shares Floating 60.81M Failed to Deliver (FTD) Shares 990 FTD / Avg. Volume 0.04%
Short Selling Information The latest short interest is 11.95M, so 17.58% of the outstanding
shares have been sold short.
Short Interest 11.95M Short % of Shares Out 17.58% Short % of Float 19.4% Short Ratio (days to cover) 4.27
Valuation Ratios The PE ratio is -2.01 and the forward
PE ratio is -1.01.
Reviva Pharmaceuticals's PEG ratio is
0.04.
PE Ratio -2.01 Forward PE -1.01 PS Ratio 0 Forward PS 0.2 PB Ratio 73.84 P/FCF Ratio -1.79 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Reviva Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.01,
with a Debt / Equity ratio of 0.56.
Current Ratio 1.01 Quick Ratio 1.01 Debt / Equity 0.56 Debt / EBITDA -0.02 Debt / FCF -0.01 Interest Coverage -1665.07
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.14M Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 19.51K Effective Tax Rate -0.07%
Stock Price Statistics The stock price has increased by -48.69% in the
last 52 weeks. The beta is -0.05, so Reviva Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.05 52-Week Price Change -48.69% 50-Day Moving Average 0.48 200-Day Moving Average 1.09 Relative Strength Index (RSI) 54.55 Average Volume (20 Days) 2,547,187
Income Statement
Revenue n/a Gross Profit n/a Operating Income -30.8M Net Income -29.92M EBITDA -29.88M EBIT -29.88M Earnings Per Share (EPS) -0.9
Full Income Statement Balance Sheet The company has 13.48M in cash and 458.15K in
debt, giving a net cash position of 13.02M.
Cash & Cash Equivalents 13.48M Total Debt 458.15K Net Cash 13.02M Retained Earnings -164.27M Total Assets 15.5M Working Capital 81.86K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -33.54M
and capital expenditures 0, giving a free cash flow of -33.54M.
Operating Cash Flow -33.54M Capital Expenditures n/a Free Cash Flow -33.54M FCF Per Share -1.01
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
